Related Experiment Video
Updated: May 17, 2025

Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
Risk Factors Related to the Development of Nonalcoholic Fatty Liver: A Systematic Review
Omaira Valencia1, Carolina López1, Esteban Vanegas-Duarte1
1Population Health, Fundación Santa Fe de Bogota, Bogota, Colombia.
Nonalcoholic fatty liver disease (NAFLD) is linked to obesity, diabetes, and lifestyle factors like poor sleep. Early identification of these risk factors is crucial for preventing severe liver conditions.
Area of Science:
- Hepatology
- Public Health
- Metabolic Disorders
Background:
- Nonalcoholic fatty liver disease (NAFLD) poses significant public health challenges due to high morbidity and mortality.
- NAFLD is closely associated with metabolic syndrome, cirrhosis, and liver cancer.
- Understanding early risk factors is critical for effective NAFLD management.
Purpose of the Study:
- To systematically review and summarize the scientific literature on early risk factors for NAFLD development.
- To identify clinical and lifestyle factors associated with NAFLD.
- To inform preventive and therapeutic strategies for NAFLD.
Main Methods:
- Systematic review of population-based cohort studies.
- Screening of studies reporting risk factors for nonalcoholic steatohepatitis (NASH) and NAFLD.
- Quality assessment using Downs and Black criteria, followed by data synthesis.
Main Results:
- Thirty publications were included, identifying key clinical risk factors: obesity, weight change, psoriasis, polycystic ovary syndrome, diabetes, thyroid disorders, and elevated serum uric acid.
- Lifestyle factors associated with NAFLD include sedentary behavior, smoking (active/passive), poor sleep quality, and consumption of carbonated beverages.
- Significant associations were found between various clinical and lifestyle factors and the risk of developing NAFLD.
Conclusions:
- Clinical and lifestyle factors are demonstrably linked to NAFLD development.
- These findings underscore the necessity for targeted preventive measures.
- Improved diagnostic and therapeutic strategies are needed to enhance metabolic, hepatic, and oncological outcomes in NAFLD patients.
More Related Videos
08:35A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
08:20Investigating the Protective Effects of Platycodin D on Non-Alcoholic Fatty Liver Disease in a Palmitic Acid-Induced In Vitro Model
Published on: December 2, 2022
Related Concept Videos
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Obesity
Stress Prevention and Stress Management Techniques IV
Inflammation